160 related articles for article (PubMed ID: 37573683)
1. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
Hermsen MA; Lechner M; Oliveira Ferrer L; Trama A; Eriksen PRG; Martinez-Balibrea E; von Buchwald C
Oral Oncol; 2023 Nov; 146():106543. PubMed ID: 37573683
[TBL] [Abstract][Full Text] [Related]
2. Design and rationale of a prospective, multi-institutional registry for patients with sinonasal malignancy.
Beswick DM; Holsinger FC; Kaplan MJ; Fischbein NJ; Hara W; Colevas AD; Le QT; Berry GJ; Hwang PH
Laryngoscope; 2016 Sep; 126(9):1977-80. PubMed ID: 27283472
[TBL] [Abstract][Full Text] [Related]
3. Translational genomics of sinonasal cancers.
Hermsen MA; Riobello C; García-Marín R; Cabal VN; Suárez-Fernández L; López F; Llorente JL
Semin Cancer Biol; 2020 Apr; 61():101-109. PubMed ID: 31560943
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and survival outcomes of sinonasal verrucous carcinoma in the United States.
Alonso JE; Han AY; Kuan EC; Suh JD; John MAS
Laryngoscope; 2018 Mar; 128(3):651-656. PubMed ID: 28865078
[TBL] [Abstract][Full Text] [Related]
5. [Sinonasal cancers].
Ferrand FR; Thariat J; Verillaud B; Le Clerc N
Rev Prat; 2022 Jan; 72(1):71-77. PubMed ID: 35258260
[TBL] [Abstract][Full Text] [Related]
6. Population-Based Results in the Management of Sinonasal and Ventral Skull Base Malignancies.
Abdou R; Baredes S
Otolaryngol Clin North Am; 2017 Apr; 50(2):481-497. PubMed ID: 28314407
[TBL] [Abstract][Full Text] [Related]
7. Spanish consensus for the management of sinonasal tumors.
López F; Grau JJ; Medina JA; Alobid I
Acta Otorrinolaringol Esp (Engl Ed); 2017; 68(4):226-234. PubMed ID: 27814782
[TBL] [Abstract][Full Text] [Related]
8. Sinonasal cancer: Analysis of oncological failures in 156 consecutive cases.
Mirghani H; Mortuaire G; Armas GL; Hartl D; Aupérin A; El Bedoui S; Chevalier D; Lefebvre JL
Head Neck; 2014 May; 36(5):667-74. PubMed ID: 23606521
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of emerging sinonasal malignancies.
Contrera KJ; Woody NM; Rahman M; Sindwani R; Burkey BB
Head Neck; 2020 Aug; 42(8):2202-2212. PubMed ID: 32212360
[TBL] [Abstract][Full Text] [Related]
10. Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.
Turri-Zanoni M; Gravante G; Castelnuovo P
Curr Oncol Rep; 2022 Jan; 24(1):55-67. PubMed ID: 35059992
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer.
López F; Lund VJ; Suárez C; Snyderman CH; Saba NF; Robbins KT; Vander Poorten V; Strojan P; Mendenhall WM; Rinaldo A; Ferlito A
Adv Ther; 2017 Oct; 34(10):2181-2198. PubMed ID: 28871554
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.
Dutta R; Dubal PM; Svider PF; Liu JK; Baredes S; Eloy JA
Laryngoscope; 2015 Nov; 125(11):2491-7. PubMed ID: 26228792
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal tumor pathology: what's new?
Franchi A
Pathologica; 2017 Mar; 109(1):9-13. PubMed ID: 28635989
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm.
Bossi P; Hermsen M; Lechner M; Franchi A
Oral Oncol; 2020 Oct; 109():104737. PubMed ID: 32340860
[No Abstract] [Full Text] [Related]
15. Significance of Tumor Stage in Sinonasal Undifferentiated Carcinoma Survival: A Population-Based Analysis.
Kuan EC; Arshi A; Mallen-St Clair J; Tajudeen BA; Abemayor E; St John MA
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):667-73. PubMed ID: 26908559
[TBL] [Abstract][Full Text] [Related]
16. [Advances in the treatment of sinonasal malignancy].
Shui CY; Li C; Sun RH; Zhou YQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 53(11):866-869. PubMed ID: 30453414
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and management of sinonasal paragangliomas: a systematic review.
Nguyen BK; Patel NM; Arianpour K; Svider PF; Folbe AJ; Hsueh WD; Eloy JA
Int Forum Allergy Rhinol; 2019 Apr; 9(4):413-426. PubMed ID: 30570216
[TBL] [Abstract][Full Text] [Related]
18. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.
Llorente JL; López F; Suárez C; Hermsen MA
Nat Rev Clin Oncol; 2014 Aug; 11(8):460-72. PubMed ID: 24935016
[TBL] [Abstract][Full Text] [Related]
20. Management of sinonasal cancers: Survey of UK practice and literature overview.
Iyizoba-Ebozue Z; Fleming JC; Prestwich RJD; Thomson DJ
Eur J Surg Oncol; 2022 Jan; 48(1):32-43. PubMed ID: 34840009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
